Search research articles
Contact Us
Filters
Showing results (111-120 of 190) with videos related to
Page
of 19
Sort By:
Anti-Cancer Drugs
|
July 18, 2000
Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma--a feasibility study
A Knuuttila, T Ollikainen, M Halme, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 1, 1999
Tumour response and radiation-induced lung injury in patients with recurrent small cell lung cancer treated with radiotherapy and concomitant interferon-alpha
M Halme, M Hallman, T Ruotsalainen, et al.
Journal of Clinical Microbiology
|
June 28, 2001
Pulmonary infection caused by an unusual, slowly growing nontuberculous Mycobacterium
S Suomalainen, P Koukila-Kähkölä, E Brander, et al.
Acta Neurologica Scandinavica
|
November 1, 1985
Memory and psychomotor impairment following high-dose interferon treatment in amyotrophic lateral sclerosis
M Iivanainen, R Laaksonen, M L Niemi, et al.
British Journal of Cancer
|
December 10, 1999
Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis
A M Björkqvist, M Wolf, S Nordling, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 1, 1987
Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lung
L R Holsti, K Mattson, A Niiranen, et al.
Carcinogenesis
|
May 20, 1999
Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen
L Xu, B J Flynn, S Ungar, et al.
Clinical Neuropharmacology
|
February 1, 1988
Effect of interferon-gamma on biogenic amine metabolism, electroencephalographic recordings, and transient potentials
M Färkkilä, M Iivanainen, M Härkönen, et al.
Scandinavian Journal of Respiratory Diseases. Supplementum
|
January 1, 1978
Clinical significance of precipitating anti-rifampicin antibodies
E Stevens, J Bloemmen, E Saerens, et al.
Molecular Cancer Therapeutics
|
February 26, 2025
Mechanisms of Response and Resistance to PSMA×CD3 Bispecifics in CD34+ Humanized Mice
Bethany K Mattson Cypert, Krista Menard, Gerald Chu, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 190) with videos related to
Sort By:
Page
of 19
Anti-Cancer Drugs
|
July 18, 2000
Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma--a feasibility study
A Knuuttila, T Ollikainen, M Halme, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 1, 1999
Tumour response and radiation-induced lung injury in patients with recurrent small cell lung cancer treated with radiotherapy and concomitant interferon-alpha
M Halme, M Hallman, T Ruotsalainen, et al.
Journal of Clinical Microbiology
|
June 28, 2001
Pulmonary infection caused by an unusual, slowly growing nontuberculous Mycobacterium
S Suomalainen, P Koukila-Kähkölä, E Brander, et al.
Acta Neurologica Scandinavica
|
November 1, 1985
Memory and psychomotor impairment following high-dose interferon treatment in amyotrophic lateral sclerosis
M Iivanainen, R Laaksonen, M L Niemi, et al.
British Journal of Cancer
|
December 10, 1999
Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis
A M Björkqvist, M Wolf, S Nordling, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 1, 1987
Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lung
L R Holsti, K Mattson, A Niiranen, et al.
Carcinogenesis
|
May 20, 1999
Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen
L Xu, B J Flynn, S Ungar, et al.
Clinical Neuropharmacology
|
February 1, 1988
Effect of interferon-gamma on biogenic amine metabolism, electroencephalographic recordings, and transient potentials
M Färkkilä, M Iivanainen, M Härkönen, et al.
Scandinavian Journal of Respiratory Diseases. Supplementum
|
January 1, 1978
Clinical significance of precipitating anti-rifampicin antibodies
E Stevens, J Bloemmen, E Saerens, et al.
Molecular Cancer Therapeutics
|
February 26, 2025
Mechanisms of Response and Resistance to PSMA×CD3 Bispecifics in CD34+ Humanized Mice
Bethany K Mattson Cypert, Krista Menard, Gerald Chu, et al.
Page
of 19